Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...
Medical Device Network on MSN17h
Alcon signs merger agreement to acquire LensarThe acquisition will include Lensar’s ALLY Robotic Cataract Laser Treatment System and Streamline software technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback